Impact of Biologic Therapy on Cancer Outcomes in Patients with Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid [SUPPLEMENT]

Name: Impact of Biologic Therapy on Cancer Outcomes in Patients with Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid [SUPPLEMENT]
Creator: Jordan Said
Published: 2022-06-24T07:39:55.593Z
Keywords: Dermatology, Oncology, Bullous Disease, Immune Checkpoint Inhibitor

Said, Jordan; Talia, Jordan; Wei, Erin; Mostaghimi, Arash; Semenov, Yevgeniy; Giobbie-Hurder, Anita; Chen, Steven; LeBoeuf, Nicole

doi:10.17632/pp8zw5hvh8.1

Impact of Biologic Therapy on Cancer Outcomes in Patients with Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid [SUPPLEMENT]

Published: 24 June 2022| Version 1 | DOI: 10.17632/pp8zw5hvh8.1

Contributors:

Jordan Said, Jordan Talia, Erin Wei, Arash Mostaghimi, Yevgeniy Semenov, Anita Giobbie-Hurder, Steven Chen, Nicole LeBoeuf

Description

This Mendeley Supplement accompanies the research letter "Impact of Biologic Therapy on Cancer Outcomes in Patients with Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid," an article published in the Journal of the American Academy of Dermatology.

Impact of Biologic Therapy on Cancer Outcomes in Patients with Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid [SUPPLEMENT]

Description

Files

Categories

Licence